Annual D&A
$57.00 K
+$4000.00+7.55%
December 31, 2023
Summary
- As of February 21, 2025, SEEL annual depreciation & amortization is $57.00 thousand, with the most recent change of +$4000.00 (+7.55%) on December 31, 2023.
Performance
SEEL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$15.00 K
$0.000.00%
June 30, 2024
Summary
- As of February 21, 2025, SEEL quarterly depreciation & amortization is $15.00 thousand, unchanged on June 30, 2024.
- Over the past year, SEEL quarterly D&A has stayed the same.
Performance
SEEL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$59.00 K
+$1000.00+1.72%
June 30, 2024
Summary
- As of February 21, 2025, SEEL TTM depreciation & amortization is $59.00 thousand, with the most recent change of +$1000.00 (+1.72%) on June 30, 2024.
- Over the past year, SEEL TTM D&A has stayed the same.
Performance
SEEL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
SEEL Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.5% | 0.0% | 0.0% |
3 y3 years | - | 0.0% | 0.0% |
5 y5 years | +39.0% | - | - |
SEEL Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | -100.0% | -71.7% | -100.0% | -37.9% | -100.0% |
5 y | 5-year | at high | -100.0% | -71.7% | -100.0% | -37.9% | -100.0% |
alltime | all time | -95.5% | -100.0% | -97.3% | -2146.7% | -95.5% | -523.7% |
Seelos Therapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2024 | - | $15.00 K(0.0%) | $59.00 K(+1.7%) |
Mar 2024 | - | $15.00 K(0.0%) | $58.00 K(+1.8%) |
Dec 2023 | $57.00 K(+7.5%) | $15.00 K(+7.1%) | $57.00 K(-40.0%) |
Sep 2023 | - | $14.00 K(0.0%) | $95.00 K(+17.3%) |
Jun 2023 | - | $14.00 K(0.0%) | $81.00 K(+20.9%) |
Mar 2023 | - | $14.00 K(-73.6%) | $67.00 K(+26.4%) |
Dec 2022 | $53.00 K(>+9900.0%) | $53.00 K(>+9900.0%) | $53.00 K(>+9900.0%) |
Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2022 | - | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 2021 | $0.00(-100.0%) | - | - |
Dec 2018 | $41.00 K(-65.0%) | $41.00 K(-278.3%) | $41.00 K(+115.8%) |
Sep 2018 | - | -$23.00 K(-330.0%) | $19.00 K(-69.8%) |
Jun 2018 | - | $10.00 K(-23.1%) | $63.00 K(-14.9%) |
Mar 2018 | - | $13.00 K(-31.6%) | $74.00 K(-36.8%) |
Dec 2017 | $117.00 K(+10.4%) | $19.00 K(-9.5%) | $117.00 K(-1000.0%) |
Sep 2017 | - | $21.00 K(0.0%) | -$13.00 K(-134.2%) |
Jun 2017 | - | $21.00 K(-62.5%) | $38.00 K(-57.8%) |
Mar 2017 | - | $56.00 K(-150.5%) | $90.00 K(-15.1%) |
Dec 2016 | $106.00 K(-64.7%) | -$111.00 K(-254.2%) | $106.00 K(-63.8%) |
Sep 2016 | - | $72.00 K(-1.4%) | $293.00 K(-1.0%) |
Jun 2016 | - | $73.00 K(+1.4%) | $296.00 K(-0.7%) |
Mar 2016 | - | $72.00 K(-5.3%) | $298.00 K(-0.7%) |
Dec 2015 | $300.00 K(+76.5%) | $76.00 K(+1.3%) | $300.00 K(+2.7%) |
Sep 2015 | - | $75.00 K(0.0%) | $292.00 K(+4.7%) |
Jun 2015 | - | $75.00 K(+1.4%) | $279.00 K(+24.6%) |
Mar 2015 | - | $74.00 K(+8.8%) | $224.00 K(+31.8%) |
Dec 2014 | $170.00 K(+120.8%) | $68.00 K(+9.7%) | $170.00 K(+39.3%) |
Sep 2014 | - | $62.00 K(+210.0%) | $122.00 K(+60.5%) |
Jun 2014 | - | $20.00 K(0.0%) | $76.00 K(0.0%) |
Mar 2014 | - | $20.00 K(0.0%) | $76.00 K(-1.3%) |
Dec 2013 | $77.00 K(-62.1%) | $20.00 K(+25.0%) | $77.00 K(-130.8%) |
Sep 2013 | - | $16.00 K(-20.0%) | -$250.00 K(-620.8%) |
Jun 2013 | - | $20.00 K(-4.8%) | $48.00 K(-61.9%) |
Mar 2013 | - | $21.00 K(-106.8%) | $126.00 K(-37.9%) |
Dec 2012 | $203.00 K(-66.3%) | -$307.00 K(-197.8%) | $203.00 K(-66.3%) |
Sep 2012 | - | $314.00 K(+220.4%) | $602.70 K(+58.4%) |
Jun 2012 | - | $98.00 K(0.0%) | $380.50 K(-16.3%) |
Mar 2012 | - | $98.00 K(+5.7%) | $454.60 K(-24.5%) |
Dec 2011 | $602.00 K(-39.1%) | $92.70 K(+1.0%) | $602.00 K(-23.4%) |
Sep 2011 | - | $91.80 K(-46.7%) | $786.30 K(-15.9%) |
Jun 2011 | - | $172.10 K(-29.9%) | $935.10 K(-4.8%) |
Mar 2011 | - | $245.40 K(-11.4%) | $982.10 K(-0.7%) |
Dec 2010 | $989.00 K | $277.00 K(+15.1%) | $989.00 K(+21.6%) |
Sep 2010 | - | $240.60 K(+9.8%) | $813.60 K(+23.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2010 | - | $219.10 K(-13.2%) | $657.30 K(+23.8%) |
Mar 2010 | - | $252.30 K(+148.3%) | $531.10 K(+37.0%) |
Dec 2009 | $387.70 K(-20.3%) | $101.60 K(+20.5%) | $387.70 K(-3.8%) |
Sep 2009 | - | $84.30 K(-9.3%) | $403.20 K(-8.3%) |
Jun 2009 | - | $92.90 K(-14.7%) | $439.90 K(-6.2%) |
Mar 2009 | - | $108.90 K(-7.0%) | $468.80 K(-3.6%) |
Dec 2008 | $486.40 K(-52.8%) | $117.10 K(-3.2%) | $486.50 K(-46.6%) |
Sep 2008 | - | $121.00 K(-0.7%) | $911.60 K(-2.7%) |
Jun 2008 | - | $121.80 K(-3.8%) | $937.20 K(-4.9%) |
Mar 2008 | - | $126.60 K(-76.7%) | $985.20 K(-4.4%) |
Dec 2007 | $1.03 M(-11.9%) | $542.20 K(+269.8%) | $1.03 M(+2.7%) |
Sep 2007 | - | $146.60 K(-13.7%) | $1.00 M(-5.7%) |
Jun 2007 | - | $169.80 K(-1.2%) | $1.06 M(-4.0%) |
Mar 2007 | - | $171.80 K(-66.6%) | $1.11 M(-5.3%) |
Dec 2006 | $1.17 M(-7.8%) | $514.70 K(+148.6%) | $1.17 M(-3.2%) |
Sep 2006 | - | $207.00 K(-3.5%) | $1.21 M(-2.5%) |
Jun 2006 | - | $214.40 K(-8.4%) | $1.24 M(-2.0%) |
Mar 2006 | - | $234.10 K(-57.7%) | $1.27 M(-0.3%) |
Dec 2005 | $1.27 M(+27.4%) | $553.60 K(+133.1%) | $1.27 M(+32.3%) |
Sep 2005 | - | $237.50 K(-1.1%) | $959.20 K(-0.5%) |
Jun 2005 | - | $240.20 K(+1.2%) | $964.20 K(-0.2%) |
Mar 2005 | - | $237.30 K(-2.8%) | $966.60 K(-3.0%) |
Dec 2004 | $996.00 K(-20.4%) | $244.20 K(+0.7%) | $996.00 K(-7.1%) |
Sep 2004 | - | $242.50 K(-0.0%) | $1.07 M(-6.9%) |
Jun 2004 | - | $242.60 K(-9.0%) | $1.15 M(-5.4%) |
Mar 2004 | - | $266.70 K(-16.7%) | $1.22 M(-2.7%) |
Dec 2003 | $1.25 M(+17.3%) | $320.30 K(-0.3%) | $1.25 M(-3.6%) |
Sep 2003 | - | $321.40 K(+4.3%) | $1.30 M(-0.1%) |
Jun 2003 | - | $308.10 K(+2.4%) | $1.30 M(+8.2%) |
Mar 2003 | - | $300.80 K(-18.0%) | $1.20 M(+12.6%) |
Dec 2002 | $1.07 M(+102.4%) | $366.70 K(+13.4%) | $1.07 M(+26.6%) |
Sep 2002 | - | $323.30 K(+54.2%) | $842.40 K(+28.5%) |
Jun 2002 | - | $209.70 K(+25.8%) | $655.50 K(+17.1%) |
Mar 2002 | - | $166.70 K(+16.8%) | $559.80 K(+6.2%) |
Dec 2001 | $527.00 K(+105.0%) | $142.70 K(+4.6%) | $526.90 K(+14.2%) |
Sep 2001 | - | $136.40 K(+19.6%) | $461.50 K(+5.8%) |
Jun 2001 | - | $114.00 K(-14.8%) | $436.30 K(+19.9%) |
Mar 2001 | - | $133.80 K(+73.1%) | $363.80 K(+41.6%) |
Dec 2000 | $257.10 K(+355.9%) | $77.30 K(-30.5%) | $257.00 K(+43.0%) |
Sep 2000 | - | $111.20 K(+168.0%) | $179.70 K(+162.3%) |
Jun 2000 | - | $41.50 K(+53.7%) | $68.50 K(+153.7%) |
Mar 2000 | - | $27.00 K | $27.00 K |
Dec 1999 | $56.40 K(-83.5%) | - | - |
Dec 1998 | $341.20 K(+976.3%) | - | - |
Dec 1997 | $31.70 K | - | - |
FAQ
- What is Seelos Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Seelos Therapeutics?
- What is Seelos Therapeutics annual D&A year-on-year change?
- What is Seelos Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly D&A year-on-year change?
- What is Seelos Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Seelos Therapeutics?
- What is Seelos Therapeutics TTM D&A year-on-year change?
What is Seelos Therapeutics annual depreciation & amortization?
The current annual D&A of SEEL is $57.00 K
What is the all time high annual D&A for Seelos Therapeutics?
Seelos Therapeutics all-time high annual depreciation & amortization is $1.27 M
What is Seelos Therapeutics annual D&A year-on-year change?
Over the past year, SEEL annual depreciation & amortization has changed by +$4000.00 (+7.55%)
What is Seelos Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SEEL is $15.00 K
What is the all time high quarterly D&A for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly depreciation & amortization is $553.60 K
What is Seelos Therapeutics quarterly D&A year-on-year change?
Over the past year, SEEL quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Seelos Therapeutics TTM depreciation & amortization?
The current TTM D&A of SEEL is $59.00 K
What is the all time high TTM D&A for Seelos Therapeutics?
Seelos Therapeutics all-time high TTM depreciation & amortization is $1.30 M
What is Seelos Therapeutics TTM D&A year-on-year change?
Over the past year, SEEL TTM depreciation & amortization has changed by $0.00 (0.00%)